Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F I Carroll

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
European Journal of Medicinal Chemistry|July 13, 2005
Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitorD E Dar, M Thiruvazhi, P Abraham, et al.
Synapse (New York, N.Y.)|December 1, 1995
Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121J K Staley, J W Boja, F I Carroll, et al.
Nuclear Medicine and Biology|August 28, 1998
In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronochloroepibatidine in rodent and human brainS J Gatley, Y S Ding, D Brady, et al.
Journal of Medicinal Chemistry|May 1, 1987
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agentF I Carroll, P Abraham, K Parham, et al.
Synapse (New York, N.Y.)|January 13, 2012
Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeysHeather L Kimmel, Jonathon A Nye, Ronald Voll, et al.
Brain Research|March 27, 1992
A cocaine analog and a GBR analog label the same protein in rat striatal membranesA Patel, J W Boja, J Lever, et al.
Neurochemical Research|February 1, 1994
Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domainsC M Dersch, H C Akunne, J S Partilla, et al.
Molecular Pharmacology|April 1, 1995
Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl esterJ W Boja, J L Cadet, T A Kopajtic, et al.
Journal of Medicinal Chemistry|July 24, 1992
Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptorsF I Carroll, P Abraham, K Parham, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptorJ B Thomas, R N Atkinson, X M Herault, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
European Journal of Medicinal Chemistry|July 13, 2005
Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitorD E Dar, M Thiruvazhi, P Abraham, et al.
Synapse (New York, N.Y.)|December 1, 1995
Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121J K Staley, J W Boja, F I Carroll, et al.
Nuclear Medicine and Biology|August 28, 1998
In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronochloroepibatidine in rodent and human brainS J Gatley, Y S Ding, D Brady, et al.
Journal of Medicinal Chemistry|May 1, 1987
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agentF I Carroll, P Abraham, K Parham, et al.
Synapse (New York, N.Y.)|January 13, 2012
Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeysHeather L Kimmel, Jonathon A Nye, Ronald Voll, et al.
Brain Research|March 27, 1992
A cocaine analog and a GBR analog label the same protein in rat striatal membranesA Patel, J W Boja, J Lever, et al.
Neurochemical Research|February 1, 1994
Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domainsC M Dersch, H C Akunne, J S Partilla, et al.
Molecular Pharmacology|April 1, 1995
Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl esterJ W Boja, J L Cadet, T A Kopajtic, et al.
Journal of Medicinal Chemistry|July 24, 1992
Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptorsF I Carroll, P Abraham, K Parham, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptorJ B Thomas, R N Atkinson, X M Herault, et al.
Pageof 21